Crossmark

Outcome of Nellix-EVAS: single center mid-term results

Crossref DOI link: https://doi.org/10.1186/s42155-019-0058-0

Published Online: 2019-04-23

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Najafi, Arash http://orcid.org/0000-0002-5151-4672
Sheikh, Gabriel Tobias

Wigger, Pius

Binkert, Christoph A.
Funding

Funding for this research was provided by:

Philips
License Information

Text and Data Mining valid from 2019-04-23
More Information

Article History

Received: 28 January 2019

Accepted: 11 April 2019

First Online: 23 April 2019

Ethics approval and consent to participate

: Ethical approval for this study was obtained from the Kantonale Ethikkommission Zürich (ID #2018–01428). All patients gave written consent to participate in this study.

: All patients gave written consent to participate in this study and for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.